MALIGNANT LYMPHOMAS have been traditionally diagnosed and classified on the basis of solely morphological criteria. Clinicopathological studies have repeatedly shown the applicability and value of the Rappaport classification (Rappaport, 1966) with recent modifications (Nathwani et al., 1976; Pangalis et al., 1977; Mann et al., 1979) (Table I) , for the non-Hodgkin's lymphomas. The classification of Hodgkin's disease (HD) originally proffered by Lukes & Butler (1966) and Lukes et al. (1966a) and later simplified by a nomenclature committee (Lukes et al., 1966b) (Table II) has simultaneously gained world-wide acceptance and usage. In recent years, however, new immunological, cytochemical, and ultrastructural techniques have made possible a sophisticated characterization of normal cells of the T-lymphocyte, B-lymphocyte, and monocyte-macrophage series (Mann et al., 1979) . Such studies have greatly enhanced 1 current understanding of the compartmentalization, immunology and function of the lymphoreticular system. Use of the same modern methodologies in studies of the neoplastic cells of malignant lymphomas has established that such cells often bear markers similar or identical to those demonstrable on normal cells. Malignant lymphomas are tumours of the immune system (Table III) and they often seem, both structurally and functionally, to be neoplastic caricatures of their normal benign counterparts (Lukes & Collins, 1974; Berard et al., , 1978 Lukes et al., 1978a, b; Mann et al., 1979) .
In our laboratory we have evaluated the neoplastic cells in suspension for spontaneous rosette (E) formation with sheep red blood cells (SRBC), receptors for complement (EAC), receptors for cytophilic antibody (IgGEA), and surface immunoglobulins (SIg) . Both polyvalent and monovalent antisera have been used to charac- (Lukes et al., 1978a,b; Mann et al., 1979 ) and our own data as selected examples, the major characteristics of the cells of these neoplastic proliferations.
NODULAR (FOLLICULAR) LYMPHOMAS
Among the non-Hodgkin's lymphomas, nodular (follicular) lymphomas are characterized by a propensity of the neoplastic cells to form cohesive aggregates resembling lymphoid follicles or germinal centres (Rappaport, 1966) . On the basis of their cytological diversity they are subelassified into 3 groups (Table I) . Most common are the lymphocytic, poorly differentiated group, in which the predominant cells are small and cytoplasm is scant. The most distinctive feature of the neoplastic cells is their indented or "cleaved" nuclear configuration, with moderately condensed chromatin, small nucleoli, and few mitotic figures. Although usually widespread at the time of clinical presentation (Chabner et al., 1977) , these neoplasms have the most favourable prognosis of the nodular lymphomas (Jones et al., 1973; Qazi et al., 1976) . Clinically most aggressive are the uncommon nodular "histiocytic" group, even though they are at diagnosis more frequently localized (Stage I or II) than other nodular lymphomas (Jones et al., 1973; Chabner et al., 1977) . If therapy does not induce a complete clinical remission, these neoplasms are characteristically rapidly progressive and fatal. Histologically they show a predominance of large cells, usually with round to oval vesicular nuclei and 1-3 prominent basophilic nucleoli. A striking feature is the tendency for one or more of the nucleoli to be located in apparent apposition to the sharply defined nuclear membrane. Mitoses are numerous, and most cells have a readily detectable rim of amphophilic cytoplasm (basophilic or pyroninophilic with special stains). A variable proportion of the large cells have indented or folded nuclei, with small nucleoli, coarse chromatin, and narrow margins of pale cytoplasm. Admixed with the large neoplastic cells there may be normal-appearing tingible-body macrophages and a smattering of small cleaved" cells identical to those of the nodular lymphocytic, poorly differentiated group. In tumours of the mixed lymphocytic-"histiocytic" group there is a more balanced admixture of large and small neoplastic cells, with mitotic activity generally paralleling the numerical frequency of the former. While sometimes comprising a distinct minority of the malignant population, the large cells should be conspicuous (10 or more in most highpower fields) in any nodular lymphoma classified as mixed.
Despite the cytological and architectural resemblance of nodular lymphomas (Kojima et al., 1973; Lennert, 1973; Jaffe et al., 1974a, b; Leech et al., 1975; Levine & Dorfman, 1975; (Table III) . We have earlier reported the presence on the neoplastic cells of avid complement receptors, also characteristic of normal follicular B lymphocytes (Jaffe et al., 1974a) . Other investigators have found readily demonstrable SIg, usually of the IgM class with or without IgD (Aisenberg & Long, 1975; Leech et al., 1975) . In any nodular lymphoma all the malignant cells belong immunologically to a single clone of follicular B lymphocytes. Our series has enlarged to a total of 49 specimens from 36 patients, confirming earlier observations (Table IV) (Fu et al., 1974) . With the use of anti-idiotypic antibody, the IgD and IgM have been shown to share the same idiotype and even the same antibody specificity. The cells of all 3 cytological groups have identical B-lymphocyte surface markers, and the older designation "histiocytic" (Rappaport, 1966) is an unfortunate misnomer resulting from a superficial resemblance of the nuclear features of the large neoplastic cells to those seen in nor-mal activated histiocytes. In frozen sections exposed to EAC, the rosetted cells are frequently exclusively confined to the malignant nodules (Jaffe et al., 1974a) . Although comprising immunologically a single neoplastic population, the large and small follicular B lymphocytes probably represent kinetic variants . The large cells are the replicative fraction, and their numerical frequency parallels the mitotic activity and clinical aggressiveness of the tumour. Sequential biopsies from the same patient may show either constancy of "histological progression" of the process. In the latter event, the shift is usually towards a prognostically graver form, i.e., from a nodular to a diffuse pattern of growth and/or from small to large neoplastic cells (Cullen et al., 1979; Risdall et al., 1979; Woda & Knowles, 1979) . Despite these alterations in histology and apparent kinetic activity, the cells of such tumours retain their follicular B-lymphocyte markers Woda & Knowles, 1979 ). An understanding of their evolution enables one to account for apparently de novo diffuse lymphomas of the poorly differentiated lymphocytic, mixed lymphocytic-"histiocytic", and "histiocytic" types with immunological markers identical to those of nodular lymphomas.
Notwithstanding the fact that the malignant cells are follicular B lymphocytes, in nodular lymphomas there are usually numerous admixed cytologically normal T cells (mean 38%, Table IV In spleens involved by nodular lymphoma the findings differed somewhat from those in lymph nodes. The central portions of the Malpighian follicles, histologically populated by malignant cells, manifested only weakly positive reactions. The reactions were strongest at the periphery of the white pulp, a zone thought to be populated normally by T cells (Craddock et al., 1971) . In spleens involved by nodular lymphoma, however, the peripheral T-cell reactions were much greater than those in any of the normal control spleens. Histologically the reactions appeared to correlate with a distinct zone containing lymphocytes and prominent immunoblasts. Only one case, which lacked this hyperplastic zone, failed to show a peripheral white-pulp reaction.
The strong binding of EN to the nodules of nodular lymphoma was not anticipated, and made it essential to confirm that the binding was due to the interaction of SRBC and T lymphocytes. Reactions in control tissues were consistent with this conclusion. There were very strong reactions in sections between thymocytes and EN. Conversely, there was essentially no binding of EN (with only rare isolated rosettes) to frozen sections of tissues infiltrated by CLL of B-cell type. Additional procedures, performed on tissues involved by nodular lymphoma, also supported the specificity of the observed reactions. Binding was inhibited by prior trypsinization of the SRBC, a procedure known to abolish E rosetting (Weiner et al., 1973) . It was suggested that the SIg of the neoplastic cells might be mediating the binding via antibody activity against SRBC, but binding of E in an identical pattern persisted after preincubation of frozen sections with anti-human immunoglobulini. Moreover, the one case of nodular lymphoma that was SIg-negative exhibited equally strong binding of EN. Additional reactions were carried out with human and rabbit red cells, since both human and rhesus monkey but not rabbit red cells have been reported to interact with human T lymphocytes in a manner similar to SRBC (O'Connell, 1973; Lohrman & Novikovs, 1974; Braganza et al., 1975; Sandilands et al., 1975) . With human red cells the reaction was weaker but qualitatively similar to that obtained with SRBC. The rabbit red cells, however, failed to manifest any specific patterns of binding to frozen sections.
All observations to date thus indicate the frequent presence of E-binding T lymphocytes in a nodular or perinodular distribution in tissues involved by nodular lymphoma. One can only speculate upon the significance of this finding. These T cells may well be reactive, since the ERFC on cytocentriftige preparations are always cytologically normal. Moreover, in diffuse "histiocytic" lymphomas occurring as "histological progression" fronm prior nodular lymphomas, the percentages of ERFC are almost always low (Table VIII) . Even in recurrent tumours which retain a nodular pattern, the % of ERFC tends to be lower than that in pretreatment biopsies (Table V) . The T cells may be a manifestation of host defence since Tlymphocyte infiltrates have been seen in other malignant tumours (Potvin et al., 1975) . Also unexplained is the relatively poor binding of EN to the internodular areas. These areas fail to bind EAC and are usually rich in normal-looking lymphocytes of presumed T-cell type. It is known that activated T lymphocytes appear to bind E more readily than T cells not stimulated or not actively involved in an immunological reaction (Wybran et al., 1972) . The so-called "active E rosette test" is based upon this observation (Wybran et al., 1972) . Perhaps the small lymphocytes in the internodular areas are an inactive, unstimulated population of T cells with little or no affinity for EN in frozen sections. Conceivably, those T cells which do bind EN in a nodular or perinodular pattern in the frozen-section assay may be a subpopulation of stimulated, immunologically active cells. Future studies of nodular lymphomas should include assays of the E-active population in cellular suspensions. As more cases are studied it may be possible to demonstrate hitherto unsuspected correlations between the T-cell component of nodular lymphomas and their clinical and pathological manifestations.
DIFFUSE LYMPHOMAS
Malignant lymphomas with a diffuse pattern of growth are morphologically and clinically heterogeneous (Rappaport, 1966; Mann et al., 1979) . This heterogeneity reflects the fact that they, unlike nodular lymphomas, are not a generic group. Sharper insights into this spectrum of tumours have evolved from recent immunological and cytochemical studies.
Lymphocytic, well differentiated
Occurring predominantly in older age groups, these tumours are usually disseminated at the time of clinical presentation (Pangalis et al., 1977 (Aisenberg & Wilkes, 1976; Braylan et al., 1976) . The SIg has in most cases been IgM, with either K or A light chains. It is not uncommon to find both IgM and IgD, but the light chain is restricted to a single class. The deficiency in complement receptors (Logue & Cohen, 1977 ) is manifested as "weak" binding of EAC in cellular suspensions and little to no binding of this reagent to frozen sections of tumour . Morphologically and immunologically, the cells of WDLL and CLL simulate the small lymphocytes of the medullary cords of normal lymph nodes. Such cells are normally in free exchange with the peripheral blood, and it is a natural biological consequence that tumours composed of their neoplastic counterparts are usually either disseminated (WDLL) or overtly leukaemic (CLL) at diagnosis (Pangalis et al., 1977 (Pangalis et al., 1977) . Notably, in the studies of this disease by Fu et at. (1978) there was no apparent defect in the helper function of T cells.
There is one final important point to be made concerning all well-differentiated (Table VII) . This case has been previously reported in detail (Nanba et al., 1977) . This enzyme has also been identified in a small percentage of nodular lymphomas (Nanba et al., 1977) 
Lymphocytic, poorly differentiated
The term "diffuse poorly differentiated lymphocytic lymphoma" (DPDL) has traditionally been applied to a heterogeneous spectrum of tumours which have only recently been more clearly delineated. Their sole unifying feature was that all seemed to be composed of proliferations of atypical and presumptively "immature" lymphocytes. At least 3 distinct neoplasms have now been identified within this generic group, and others may well be defined in future. The first is lymphoblastic lymphomna (Nathwani et al., 1976) historically a form of DPDL most common in children and young adults. This disease has now become so well established as a specific clinicopathological entity that it should be diagnosed and discussed (vide infra) separately from the remainder of DPDL Bloomfield et al., 1977) .
The third category presently known to exist within DPDL may arise from peripheral T lymphocytes (Jaffe et al., 1975; Waldron et al., 1977) in contrast to the origin of lymphoblastic lymphomas from thymus-committed T lymphoblasts. While uncommon in the United States, such tumours appear to have a greater frequency in Japan (Uchiyama et al., 1977; Suchi et al., 1979 (Jaffe et al., 1975; Waldron et al., 1977) . Mycosis fungoides and Sezary's syndrome, although not included in most classifications of nonHodgkin's lymphomas, are also peripheral T-lymphocyte malignancies (Brouet et al., 1973; Flandrin & Brouet, 1974; Lutzner et al., 1975; Robinowitz et al., 1976 ).
Large cell lymphomas: "histiocytic", mixed lymphocytic-"histiocytic", and undifferentiated pleormorphic (non-Burkitt's) Diffuse lymphomas composed of large or medium-sized cells, or a mixture of the two have been categorized morphologically as "histiocytic", undifferentiated pleomorphic (non-Burkitt's), or mixed lymphocytic-"histiocytic", respectively. These tumours occur in both children and adults, but their incidence increases with age. Despite their propensity for extranodal presentations and relatively localized disease (Stage I or II) at the time of diagnosis (Chabner et al., 1977) in general they pursue an aggressive clinical course with poor prognosis (Jones et al., 1973) . In this group of patients, however, recent trials of combination chemotheapy have been encouraging. If therapy does yield a well-documented complete clinical and pathological remission, there is a good chance for potential cure of the disease (Schein et al., 1974 (Schein et al., , 1976 .
These tumouirs have marked cytological heterogeneity, and histologically are often difficult to classify reproducibly. Considerable effort has been directed to studying their immunological and cytochemical markers, which in published reports are also diverse (Peter & MacKenzie, 1974; Aisenberg & Long, 1975; Habeshaw & Stuart, 1975; Leech et al., 1975; Morris & Davey, 1975; Bloomfield et al., 1976; Brouet et al., 1976; Davey et al., 1976; Bloomfield et al., 1977; Lawrence et al., 1978; Lukes et al., 1978a, b; Mann et al., 1979; Pinkus et al., 1979; Suchi et al., 1979; Woda & Knowles, 1979 (Fialkow et al., 1973; Mann et al., 1976) . These findings are not surprising since IgM is the immunoglobulin most frequently identified on B lymphocytes from normal peripheral blood (Aisenberg, 1973) . One case bore only K light chains, without detectable heavy chains; however, this case was not evaluated for the presence of IgD. In none of these 13 B lymphocyte tumours was there significant hydrolytic-enzyme activity. Seven of the 25 large-cell lymphomas were from patients with a previous history of biopsy-proven nodular (follicular) lymphoma; these 7 invariably manifested B-cell markers. Such instances of "histological progression" with retention of markers appear to reflect heightened transformation and/or kinetic advantage within the neoplastic population. A similar phenomenon occurs in CML, with retention of the Ph' chromosome during blastic transformation. Identical findings have been reported with other lymphoid neoplasms, most notably blastic transformation of CLL ) and largecell lymphomas supervening on CLL (Richter's syndrome) (Long & Aisenberg, 1975; Brouet et al., 1976) . In rare cases with immunological studies of both the antecedent well-differentiated proliferation and the blastic tumour, the membranebound immunoglobulins have shown persistence of the same light and heavy chains, a finding which supports the concept that both specimens belonged to a single neoplastic clone. T-lymphocyte markers were demonstrated in 4/25 cases (16%,' ). The malignant cells formed E rosettes and also had abundant granular reactivity for acid phosphatase and 3-glucuronidase. Comparable enzymatic reactivity has been observed in other T-lymphocyte neoplasms, including Sezary's syndrome (Flandrin & Brouet, 1974 ) chronic lymphocytic leukaemia of T-cell type and lymphoblastic lymphoma (Catovsky et al., 1974; Stein et al., 1976) .
Of particular interest was the fact that 1 of the 4 tumours with T-lymphocyte markers arose suddenly in a cervical lymph node of a 65-year-old white male with previously well-studied Sezary's syndrome. It was classified histologically as an undifferentiated lymphoma of non-Burkitt's type. The neoplastic cells, however, like the patient's Sezary's cells in earlier studies, manifested both T-cell surface characteristics and the ability to function as "helper" T cells for immunoblobulin synthesis by normal B lymphocytes in vitro (Lawrence et al., 1978) . As previously described with B-lymphocyte tumours, it thus appears that a malignancy of more differentiated T cells may undergo "histologic progression" and yet retain surface and fuinctional properties characteristic of T lymphocytes. In 1 of the 25 cases (40o) the markers were consistent with a true h.istiocytic neoplasm. The neoplastic cells were devoid of SIg but formed rosettes with both EAC and IgGEA. Additionally, they phagocytosed the bound erythrocytes, a phenomenon restricted in our experience to cells of the monocyte-macrophage series. They were rich in hydrolytic enzymes, with diffuse strong cytoplasmic activity for AP, A-EST, BG, and NASDA and weak staining for B-EST. This neoplasm arose in a 14-year-old boy and, unlike the other large-cell lymphomas in this series, appeared to be primary in bone (clavicle).
No immunological markers were detected in the remaining 7 cases (28%); 2 of them, however, were not evaluated for SIg. In 3 cases the malignant cells contained AP and A-EST: one of these was also studied for BG, with positive findings. The cytochemical staining pattern, however, was not diffuse as expected with cells of the monocyte-macrophage series. Instead, the enzymatic reaction was manifested as discrete punctate dots, often restricted to the Golgi zone. This pattern of reactivity occurs in lymphocytes, both normal and neoplastic. It has been reported in T-cell tumours, but these cases lacked T-cell markers. All 3 of these cases were also studied for and lacked terminal deoxynucleotidyl transferase (TdT) (Bollum, 1979) . All 3 had plasmacytoid features, and 2 examined in the electron microscope had moderate to abundant rough endoplasmic reticulum (Fisher et al., 1976) . Strong AP activity can be demonstrated in mature plasma cells and the neoplastic cells of multiple myeloma. Unlike such cells, however, the malignant cells of these lymphomas were devoid of demonstrable cytopla,smic immunoglobulin. In one of the "null" cases [389] attempts were made to detect TdT, using both a biochemical assay and indirect immunofluorescence (Bollum, 1979) . Although the biochemical assay was positive, immunofluorescence failed to confirm this. Since, in a series of more than 50 cases, this is the sole instance in which immunofluorescence failed to confirm the biochemical assay, the positivity of this case for TdT remains dubious. Undifferentiated, Burkitt's type Although there are clinical differences between patients with Burkitt's lymphoma in endemic areas of East Africa and those in non-endemic regions of the world, the tumours are histologically identical (Banks et al., 1975 . The cytological uniformity mirrors the kinetic uniformity of the neoplastic cells. In untreated cases the disease is very aggressive and usually rapidly fatal, but gratifying results have been obtained with modern intensive chemotherapy in both African and American patients (Ziegler, 1977) .
Immunologically the neoplastic B cells from both patient populations are identical. They characteristically have abundant monoclonal SIg, usually of the IgM class, but inconstantly manifest receptors for complement (Fialkow et al., 1973; Mann et al., 1976) . Within the cells there is little or no demonstrable activity of hydrolytic enzymes. Lukes & Collins (1974) have likened the cells of Burkitt's lymphoma cytologically to small noncleaved cells of germinal centres. To pursue this suggestion, we thoroughly reviewed all the histopathological sections from 47 biopsy and 17 necropsy specimens, specifically to assess patterns of neoplastic proliferation in lymph nodes, spleens, and Peyer's patches. In 10 biopsy and 2 necropsy specimens, there was selective involvement of germinal centres by Burkitt's tumour. Data both from human cases and experiments in animals support the concept of a relationship between the cells of Burkitt's tumour and some B lymphocytes of normal germinal centres (Mann et al., 1976; Mann & Berard, 1977) . Nevertheless, the site of origin of Burkitt's lymphoma in man has yet to be conclusively demonstrated.
Lymphoblastic
Lymphoblastic lymphoma is now recognized as a specific clinicopathological entity (Nathwani et al., 1976; (Nathwani et al., 1976) . With modern intensive therapy, however, of the type used for acute lymphoblastic leukaemia, the outlook has improved markedly (Weinstein et al., 1979 The frequent association of lymphoblastic lymphoma with an anterior mediastinal mass at presentation led early on to the suggestion of a link between this tumour and the thymus gland (Webster, 1961) . Moreover, the observation of selective neoplastic infiltration of the paracortical T cell regions of partially involved lymph nodes strengthened the hypothesis that this lymphoma was closely related to T lymphocytes. In view of these indirect observations it is not surprising that Tcell markers have been identified in most cases. The malignant cells have in particular the surface, cytochemical and biochemical features of immature thymocytes (Kaplan et al., 1974; Gatien et al., 1975; Coccia et al., 1976; Jaffe et al., 1976; Stein et al., 1976; Donlon et al., 1977; Stein & Muller-Hermelink, 1977; Kersey et al., 1978; Kung et al., 1978; Lukes et al., 1978a, b; Bollum, 1979; Long et al., 1979) . The marked propensity for progression to leukaemia establishes a continuum between these tumours and a subset of acute lymphoblastic leukaemia (ALL), i.e., the 25% of cases of ALL with T-cell markers (Kersey et al., 1973; Sen & Borella, 1975; Tsukimoto et al., 1976 (Catovsky et al., 1974) . In our series of lymphoblastic lymphomas, cases which did not form E rosettes tended to manifest AP activity as a diffuse multigranular reaction. All cases studied were positive for TdT (Donlon et al., 1977; Bollum, 1979) . The heterogeneity of markers in this series confirms our earlier experience . Conceptually these tumours seem to recapitulate different stages in the (Gatien et al., 1975; Stein & Muller-Hermelink, 1977) , complement receptors seem to be present on the most primitive cells and are lost as the cells differentiate or "mature". TdT is present in all cases but the development of sharply localized acid phosphatase activity seems to correlate with appearance of the ability to form E rosettes. Hodgkin's disease Despite impressive clinical advances in the diagnosis, staging, and therapy of patients with H.D. there is still no definitive evidence for the nature of the neoplastic cells in this condition (Long, 1979) . Because of the complex composition of the cellular proliferation, there are unavoidable difficulties in isolating and characterizing the neoplastic cells. In most non-Hodgkin's lymphomas and leukaemias, the malignant populations are fairly homogeneous and studies of cellular suspensions may readily reveal their nature. In contrast, H.D. is composed of individual malignant cells distributed amidst presumed reactive elements which usually comprise the bulk of the tumefaction. This interaction of reactive and malignant cells has been confirmed by the documentation of both euploid and aneuploid populations in H.D. lesions (Peckham & Cooper, 1969 (Leech, 1973; Braylan et al., 1974) . In an attempt to circumvent these problems, some investigators have recently tried to characterize the neoplastic cells either in situ (i.e., in frozen or paraffin-embedded tissue sections) or in long-term tissue culture.
Although classically interpreted on morphological grounds as probably deriving from "reticulum cells" or histiocytes (Rappaport, 1966) Reed-Sternberg cells in early histochemical studies lacked the enzymatic apparatus of cells of the monocyte-macrophage series (Dorfman, 1961 (Glick et al., 1976) .
H.D. shows strong evidence ofa derangement of the T-cell limb of the immune system (Long, 1979) . Untreated patients with newly diagnosed and even localized disease may exhibit functionally deficient T-cell-mediated immune responses, such as impaired delayed hypersensitivity (Young et al., 1973) prolonged retention of cutaneous grafts (Kelly et al., 1960) , and increased susceptibilitv to certain infectious organisms (Casazza et al., 1966 (Fuks et al., 1976) . Also linking H.D. to the T-cell system is the often striking preferential localization of tumour within thymic-dependent paracortical regions of partially involved lymph nodes. On the basis of these indirect clues, some investigators have suggested that the Reed-Sternberg cell is a transformed T lymphocyte, perhaps antigenically altered by viral infection (Order & Hellman, 1972; DeVita, 1973; Biniaminov & Ramot, 1974 (Boecker et al., 1975; Kay & Kadin, 1975; Schmitt et al., 1977; Stuart et al., 1977) .
The finding of immunoglobulins, both within (Garvin et at., 1974 : Taylor, 1974 , 1976 Payne et al., 1976) and on the surface (Kadin et al., 1974; Boecker et al., 1975) (Garvin et al., 1974; Taylor, 1974 Taylor, , 1976 Kadin et al., 1978; Poppema et al., 1978) . Certainly the mere presence of immunoglobulin, without evidence of endogenous synthesis, does not identify a cell as a B lymphocyte. Receptors for the Fc portion of IgG have been demonstrated on Reed-Sternberg cells (Jaffe et al., 1974b; Payne et al., 1976) and recent in vitro studies have directly documented the internalization of exogenous IgG and phagocytosis of immune complexes by viable Reed-Sternberg cells (Kadin et al., 1978) . Additionally, patients with active H.D. have been shown to have circulating immune complexes (Amlot et al., 1976) . These complexes appear to bind specifically to cell lines established in long-term culture from spleens involved by H.D. (Long et al., 1977a) . Analogous binding may occuir in vivo and account for the presence of immunoglobulin on the surface of and within the malignant cells. There is thus no definitive proof of a B-cell origin of Reed-Sternberg cells.
In vitro studies of viable Reed-Sternberg cells have suggested derivation from macrophages (Kadin et al., 1978) . Support for this possibility has come from 3 laboratories independently studying longterm cultures of cells established in vitro from H.D. tumors (Kaplan & Gartner, 1977; Long et al., 1977b; Roberts et al., 1978 
